Actionable news
0
All posts from Actionable news
Actionable news in LBIO: LION BIOTECHNOLOGIES Inc COMMON STOCK,

Lion Biotechnologies, Inc. releases salary data. CEO sees compensation fall -80%

Lion Biotechnologies, Inc. just filed its annual proxy statement, which details the salary information of its key executives. In 2015, the company's CEO made 1,001,453.

The table is included below:

Name and Principal Position Year Salary Bonus Stock
Awards (6)
Option
Awards (6)
All other
Compensation
Total
Elma Hawkins, Ph.D. 2015 $ 400,000 $ 160,000 - $ 441,453 - $ 1,001,453
President and Chief Operating Officer(1) 2014 $ 277,292 $ 59,583 $ 1,120,000 (2) $ 3,637,924 (2) - $ 5,094,799
Molly Henderson, current Chief Financial Officer (2) 2015 $ 154,247 $ 40,104 - $ 2,294,159 - $ 2,488,510
James Bender, Ph.D. 2015 $ 216,300 $ 55,697 - $ 206,889 - $ 478,886
Vice President-Manufacturing(3) 2014 $ 207,712 $ 82,500 $ 959,840 $ 1,249,716 - $ 2,499,768
Laszlo Radvanyi, Ph.D.(4) 2015 $ 217,508 - - - $ 217,508
Former Chief Scientific Officer 2014 $ 130,769 $ 56,458 $ 1,171,800 $ 1,369,068 - $ 2,728,095
Michael Handelman(5) 2015 $ 116,077 - - - - $ 116,077
Former Chief Financial Officer 2014 $ 180,000 $ 45,000 $ 641,250 $ 887,507 - $ 1,753,757
2013 $ 180,000 - - - - $ 180,000

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Lion Biotechnologies, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 28, 2016

Lion Biotechnologies, Inc.'s Chief Medical Officer just declared ownership of no shares of Lion Biotechnologies, Inc. - April 21, 2016
Changes in Registrants Certifying - April 7, 2016